Evidence map›Paper›PMID 41209519›Full record

ArticleRSC advances2025

NaHMDS/B(C

Guangshuai Zhang, Xin Chen, Yan Liu, Rui Peng, Mengwei Xu, Si Yan, Jin Xiao, Zishu Liu, Qing Min, Gang Liao and 2 more

Abstract read
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Guangshuai ZhangNational Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, TCM Precision Medicine Research Department, FuRong Laboratory, Hunan University of Chinese Medicine Changsha 410208 P.R. China shuanglin@tju.edu.cn.
Xin ChenEngineering Research Center of Health Food Design & Nutrition Regulation, School of Chemical Engineering and Energy Technology, Dongguan University of Technology Dongguan 523808 P.R. China.
Yan LiuXiangya School of Pharmaceutical Sciences, Furong Laboratory, Central South University Changsha 410083 Hunan China.
Rui PengHubei Engineering Research Center of Traditional Chinese Medicine of South Hubei Province, School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology Xianning 437100 P.R. China.
Mengwei XuHubei Engineering Research Center of Traditional Chinese Medicine of South Hubei Province, School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology Xianning 437100 P.R. China.
Si YanHubei Engineering Research Center of Traditional Chinese Medicine of South Hubei Province, School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology Xianning 437100 P.R. China.
Jin XiaoNational Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, TCM Precision Medicine Research Department, FuRong Laboratory, Hunan University of Chinese Medicine Changsha 410208 P.R. China shuanglin@tju.edu.cn.
Zishu LiuNational Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, TCM Precision Medicine Research Department, FuRong Laboratory, Hunan University of Chinese Medicine Changsha 410208 P.R. China shuanglin@tju.edu.cn.
Qing MinHubei Engineering Research Center of Traditional Chinese Medicine of South Hubei Province, School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology Xianning 437100 P.R. China.
Gang LiaoXiangya School of Pharmaceutical Sciences, Furong Laboratory, Central South University Changsha 410083 Hunan China.
Xiaoji WangEngineering Research Center of Health Food Design & Nutrition Regulation, School of Chemical Engineering and Energy Technology, Dongguan University of Technology Dongguan 523808 P.R. China.
Shuanglin QinNational Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, TCM Precision Medicine Research Department, FuRong Laboratory, Hunan University of Chinese Medicine Changsha 410208 P.R. China shuanglin@tju.edu.cn.ORCID https://orcid.org/0000-0003-3022-7233

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study proposed an innovative and pragmatic approach to the asymmetric Friedel-Crafts reaction by employing indoles/pyrroles and chiral

Identifiers

PMID41209519
PMCPMC12593423

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.